Evo Fund lowers stake in SymBio Pharmaceuticals to 32.27%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2025-11-17 12:04 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 32.27%, previous report: 32.80%.